13F
← All fund report cards

Capital International Investors

13F equity value
$426.5B
Positions
438
Top 10 concentration
30.8%
Quarters / total new picks
32 / 627
13F equity value over time
$0M$319B$638B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.8% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 53.1% of quarters (excess t = 0.28, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+0.4%
t-stat
0.28
Quarterly win rate
53%
Annualized excess
+3.6%
$1 → follow vs universe
$2.70 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.02220180630: follow 1.09920180930: follow 1.13920181231: follow 1.12920190331: follow 1.13320190630: follow 1.23520190930: follow 1.28720191231: follow 1.11020200331: follow 1.32620200630: follow 1.47120200930: follow 1.85820201231: follow 1.85020210331: follow 1.98120210630: follow 2.14120210930: follow 1.73620211231: follow 1.36020220331: follow 1.46120220630: follow 1.27220220930: follow 1.43820221231: follow 1.37220230331: follow 1.41420230630: follow 1.38620230930: follow 1.71220231231: follow 1.87120240331: follow 2.25620240630: follow 2.47520240930: follow 2.41520241231: follow 2.25120250331: follow 2.31720250630: follow 2.38120250930: follow 2.62820251231: follow 2.701 0.84 1.88 2.92 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 438 · 2026 Q1

Ticker Value Weight QoQ
AVGO $26.0B
6.1%
TRIM
MSFT $20.3B
4.8%
TRIM
NVDA $17.0B
4.0%
TRIM
GOOG $13.1B
3.1%
TRIM
PM $12.0B
2.8%
TRIM
META $10.2B
2.4%
TRIM
AAPL $9.2B
2.2%
TRIM
AMZN $9.1B
2.1%
TRIM
GOOGL $7.3B
1.7%
TRIM
V $7.2B
1.7%
ADD
WELL $7.1B
1.7%
TRIM
RCL $6.9B
1.6%
TRIM
AZN $6.7B
1.6%
NEW
TDG $6.4B
1.5%
TRIM
SHOP $5.9B
1.4%
ADD
LLY $5.6B
1.3%
TRIM
GE $5.4B
1.3%
TRIM
MA $5.3B
1.3%
TRIM
TTE $4.8B
1.1%
HOLD
NOC $4.8B
1.1%
TRIM

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.